Gokulu, Sevki GoksunKilcar, Ayfer YurtBilgi, AhmetKaratay, Kadriye BusraYildirim, NuriKayas, CansuTerek, Mustafa Cosan2021-05-032021-05-0320210236-57311588-27800236-57311588-2780https://doi.org/10.1007/s10967-020-07509-7https://hdl.handle.net/11454/69955Nowadays plant origin compounds with anti-cancer properties come into prominence, among them is curcumin (CUR) with a remarkable anti-cancer activity against various cancers. CUR was nanoformulated (CUR-PLGA) by the polymer based poly(lactic-co-glycolic acid) (PLGA) and both CUR and CUR-PLGA were radiolabeled with iodine-131 radionuclide for investigation of their in vitro behaviour on Human cervix adenocarcinoma (HeLa) and Ovarian endometrioid adenocarcinoma (MDAH-2774) cell lines. The newly described radiolabeled CUR and CUR-PLGA may be initiative discovery of novel potential imaging and therapeutic agents.en10.1007/s10967-020-07509-7info:eu-repo/semantics/closedAccessCurcumin (CUR)Poly(lactic-co-glycolic acid) (PLGA)EncapsulationRadiolabelingIodine-131 (I-131)Cervical and ovarian cancer cell linesArticle3271299305WOS:0006048552000092-s2.0-85098852424Q2Q2